Search - tctmd.com

Displaying 121 - 140 of 405

Sort: Relevancy | Date

News Conference News EuroPCR 2023

Meta-analysis Finds No Excess Mortality Risk With Coronary Revascularization

Michael O'Riordan

May 19, 2023

News Conference News EuroPCR 2023

Renal Denervation: Exploring Its Potential Beyond Hypertension

Todd Neale

May 18, 2023

News Daily News

Sugary Drinks Up CVD and All-Cause Mortality Risks in Type 2 Diabetes

Michael O'Riordan

May 01, 2023

News Daily News

BASIL-2 Supports Endo-First Strategy for CLTI With Infrapopliteal Disease

L.A. McKeown

May 01, 2023

News Daily News

Ezetimibe Plus Moderate-Dose Statins May Aid Compliance in the Elderly

Yael L. Maxwell

April 03, 2023

News Daily News

Mediterranean, Low-Fat Diets Both Good for Health: Network Meta-analysis

Caitlin E. Cox

March 30, 2023

News Conference News ACC 2023

No Downside to Immediate Complete Revascularization in ACS: BIOVASC

Michael O'Riordan

March 06, 2023

News Opinion Editor's Corner ACC 2023

What’s Going to Be Hot at ACC/WCC 2023?

Shelley Wood

February 27, 2023

News Daily News

Vast Majority of HFrEF Patients Eligible for Vericiguat

L.A. McKeown

February 08, 2023

News Daily News

Extracorporeal CPR Hits Snag in INCEPTION, but Some See Unmet Promise

L.A. McKeown

January 26, 2023

News Daily News

Vegan Soul Food Study Raises Interesting Questions About ‘Healthy’ Diets

L.A. McKeown

January 18, 2023

News Daily News

Top General Cardiology and Prevention News of 2022

Michael O'Riordan

December 26, 2022

News Daily News

Reduction in BP Drives Treatment Preference for Hypertensive Patients

Michael O'Riordan

December 20, 2022

News Daily News

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Michael O'Riordan

December 14, 2022

News Daily News

Large Review Plumbs Possibilities, Pointlessness of Antioxidant Supplements

Michael O'Riordan

December 07, 2022

News Features

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

L.A. McKeown

December 02, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2022

Caitlin E. Cox

December 01, 2022

News Conference News AHA 2022

RESPECT-EPA: Missed Primary Endpoint but Hints of Benefit With Icosapent Ethyl

Todd Neale

November 10, 2022

News Conference News AHA 2022

Endothelin Receptor Antagonist Effective in Resistant Hypertension: PRECISION

Michael O'Riordan

November 09, 2022

News Conference News AHA 2022

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

Todd Neale

November 09, 2022

Advertisement

Meta-analysis Finds No Excess Mortality Risk With Coronary Revascularization

Renal Denervation: Exploring Its Potential Beyond Hypertension

Sugary Drinks Up CVD and All-Cause Mortality Risks in Type 2 Diabetes

BASIL-2 Supports Endo-First Strategy for CLTI With Infrapopliteal Disease

Ezetimibe Plus Moderate-Dose Statins May Aid Compliance in the Elderly

Mediterranean, Low-Fat Diets Both Good for Health: Network Meta-analysis

No Downside to Immediate Complete Revascularization in ACS: BIOVASC

What’s Going to Be Hot at ACC/WCC 2023?

Vast Majority of HFrEF Patients Eligible for Vericiguat

Extracorporeal CPR Hits Snag in INCEPTION, but Some See Unmet Promise

Vegan Soul Food Study Raises Interesting Questions About ‘Healthy’ Diets

Top General Cardiology and Prevention News of 2022

Reduction in BP Drives Treatment Preference for Hypertensive Patients

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Large Review Plumbs Possibilities, Pointlessness of Antioxidant Supplements

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

TCTMD’s Top 10 Most Popular Stories for November 2022

RESPECT-EPA: Missed Primary Endpoint but Hints of Benefit With Icosapent Ethyl

Endothelin Receptor Antagonist Effective in Resistant Hypertension: PRECISION

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content